Evidence map›Paper›PMID 25798213›Full record

ArticleAmerican journal of neuroprotection and neuroregeneration2014

Cerebrolysin Accelerates Metamorphosis and Attenuates Aging-Accelerating Effect of High Temperature in Drosophila Melanogaster.

V Navrotskaya, G Oxenkrug, L Vorobyova, H Sharma, D Muresanu, P Summergrad

Open access · greenAbstract read
In one paragraph

Article in American journal of neuroprotection and neuroregeneration, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

V NavrotskayaDepartment of Genetics and Cytology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.
G OxenkrugNeuroinflammation Program, Department of Psychiatry, Tufts University/Tufts Medical Center, Boston, MA, USA.
L VorobyovaDepartment of Genetics and Cytology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.
H SharmaCerebrovascular Research Laboratory, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, Uppsala, Sweden.
D MuresanuDepartment of Neurology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
P SummergradNeuroinflammation Program, Department of Psychiatry, Tufts University/Tufts Medical Center, Boston, MA, USA.
V. N. Karazin Kharkiv National University · UAIuliu Hațieganu University of Medicine and Pharmacy · ROTufts Medical Center · USTufts University · USUppsala University Hospital · SE

Funding

Depression, insulin resistance and xanthurenic acid in hepatitis C virus patientsR03MH104810 · NIMH · TUFTS MEDICAL CENTER · PI OXENKRUG, GREGORY F · 2014 to 2015
$175k
NIMH NIH HHS R03 MH104810
6 · The paper itself

Abstract

Cerebrolysin® (CBL) is a neuroprotective drug used for the treatment of neurodegenerative diseases. CBL's mechanisms of action remain unclear. Involvement of tryptophan (TRP)-kynurenine (KYN) pathway in neuroprotective effect of CBL might be suggested considering that modulation of KYN pathway of TRP metabolism by CBL, and protection against eclosion defect and prolongation of life span of Drosophila melanogaster with pharmacologically or genetically-induced down-regulation of TRP conversion into KYN. To investigate possible involvement of TRP-KYN pathway in mechanisms of neuroprotective effect of CBL, we evaluated CBL effects on metamorphosis and life span of Drosophila melanogaster maintained at 23 °C and 28 °C ambient temperature. CBL accelerated metamorphosis, exerted strong tendency (

Indexed as

AgingCerebrolysinDrosophilaEclosionHigh TemperatureKynurenineLife SpanMetamorphosisNeuroprotectionTryptophan

Identifiers

PMID25798213
PMCPMC4367862
OpenAlexW2314002234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.